Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference48 articles.
1. Marty Pyke R, Thompson WK, Salem RM, Font-Burgada J, Zanetti M, Carter H (2018) Evolutionary pressure against mhc class II binding cancer mutations. Cell 175(7):1991.
https://doi.org/10.1016/j.cell.2018.11.050
2. Hunder NN, Wallen H, Cao J, Hendricks DW, Reilly JZ, Rodmyre R, Jungbluth A, Gnjatic S, Thompson JA, Yee C (2008) Treatment of metastatic melanoma with autologous CD4 + T cells against NY-ESO-1. N Engl J Med 358(25):2698–2703.
https://doi.org/10.1056/NEJMoa0800251
3. Tran E, Turcotte S, Gros A, Robbins PF, Lu YC, Dudley ME, Wunderlich JR, Somerville RP, Hogan K, Hinrichs CS, Parkhurst MR, Yang JC, Rosenberg SA (2014) Cancer immunotherapy based on mutation-specific CD4 + T cells in a patient with epithelial cancer. Science 344(6184):641–645.
https://doi.org/10.1126/science.1251102
4. Linnemann C, van Buuren MM, Bies L, Verdegaal EM, Schotte R, Calis JJ, Behjati S, Velds A, Hilkmann H, Atmioui DE, Visser M, Stratton MR, Haanen JB, Spits H, van der Burg SH, Schumacher TN (2015) High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4 + T cells in human melanoma. Nat Med 21(1):81–85.
https://doi.org/10.1038/nm.3773
5. Fujiwara H, Fukuzawa M, Yoshioka T, Nakajima H, Hamaoka T (1984) The role of tumor-specific Lyt-1 + 2- T cells in eradicating tumor cells in vivo I. Lyt-1 + 2- T cells do not necessarily require recruitment of host’s cytotoxic T cell precursors for implementation of in vivo immunity. J Immunol 133(3):1671–1676
Cited by
65 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献